Preclinical data from SARS-CoV-2 mRNA vaccine

被引：0
|
作者：
Nicolas Vabret
机构：
[1] Icahn School of Medicine at Mount Sinai,Sinai Immunology Review Project
来源：
Nature Reviews Immunology | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 461
相关论文
共 50 条
  • [31] Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
    Grunau, Brian
    Goldfarb, DavidM.
    Asamoah-Boaheng, Michael
    Golding, Liam
    Kirkham, Tracy L.
    Demers, Paul A.
    Lavoie, Pascal M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (03): : 279 - 281
  • [32] A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine
    Young, J.
    Mercieca, L.
    Ceci, M.
    Pisani, D.
    Betts, A.
    Boffa, M. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : 12 - E16
  • [33] Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
    Yildiz, Elif
    Timur, Burcu
    Guney, Gurhan
    Timur, Hakan
    MEDICINE, 2023, 102 (20) : E33824
  • [34] SARS-CoV-2 mRNA vaccine: Sometimes life needs a boost
    Lo, Carson Ka-Lok
    Kumar, Deepali
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (05)
  • [35] Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine
    Grunenwald, Solange
    Lethellier, Gabriel
    Imbert, Philippe
    Dekeister, Celine
    Caron, Philippe
    CLINICAL CASE REPORTS, 2022, 10 (06):
  • [36] Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants
    Tan, Shudan
    Zhao, Jinghua
    Hu, Xue
    Li, Yufeng
    Wu, Zihan
    Lu, Guoliang
    Yu, Zhaoli
    Du, Binhe
    Liu, Yan
    Li, Li
    Chen, Yuchen
    Li, Ye
    Yao, Yanfeng
    Zhang, Xiaoyu
    Rao, Juhong
    Gao, Ge
    Peng, Yun
    Liu, Hang
    Yuan, Zhiming
    Liu, Jia
    Wang, Qianran
    Hu, Hengrui
    Gao, Xiaobo
    Zhou, Hui
    Yu, Hang
    Xu, Yingjie
    Yu, Wei
    Feng, Lin
    Wang, Manli
    Shan, Chao
    Lu, Jing
    Lin, Jinzhong
    SCIENCE BULLETIN, 2023, 68 (24) : 3192 - 3206
  • [37] Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection
    Roberto Stellini
    Renzo Gianello
    Angelo Meloni
    Elia Croce
    Paola Materzanini
    Walter Gomarasca
    Infection, 2022, 50 : 791 - 793
  • [38] Inactivated vaccine for SARS-CoV-2
    Emma Risson
    Nature Reviews Immunology, 2020, 20 : 353 - 353
  • [39] SARS-CoV-2 mucosal vaccine
    Stephanie Houston
    Nature Immunology, 2023, 24 : 1 - 1
  • [40] SARS-CoV-2 mucosal vaccine
    Houston, Stephanie
    NATURE IMMUNOLOGY, 2023, 24 (01) : 1 - 1
12345